Friday, July 24, 2026

< + > Breaking Clinical Data Chaos – Life Sciences Today Podcast Episode 71

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Raj Indupuri, Co-Founder and CEO at eClinical Solutions. Why is clinical development still run like a sequence of handoffs instead of a continuous learning system? In this episode, I talk with Indupuri about the industry’s biggest anti-pattern: milestone-based, sequential trials. We discuss clinical data chaos, AI in regulated environments, the real moat behind trusted execution, and how sponsors are starting to treat clinical data as core IP. We also dig into switching costs, CRO channel conflict, and what Indupuri says eClinical will deliver for customers over the next 12 months: faster cycle times, less manual work, and more agile decision-making.

Check out the main topics of discussion for this episode of the Life Sciences Today podcast:

  • What’s the biggest anti-pattern in the industry?
  • Tell me about your personal journey.
  • How do you create value?
  • How do you capture value?
  • You work with sponsors and CROs – how do you handle channel conflict?
  • What is your moat? What does a greenfield competitor building this today get right that you can’t?
  • What are three things you are going to do for your customers in the next twelve months?

Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.

Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:

Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube.  Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.

If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.

Thanks so much for listening!



< + > Lyric Acquires Concert | SpinSci Acquires Dialog Health

Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.


Lyric Acquires Concert to Advance Healthcare Decision Intelligence and Expand the Lyric42 Platform

Acquisition Reinforces Lyric’s Commitment to Healthcare Decision Intelligence Across the Healthcare Ecosystem

Lyric, a trusted leader in healthcare decision intelligence for payment accuracy, today announced its acquisition of Concert, a precision health payment accuracy leader with proprietary technology for translating machine-readable policies into real-time decisions.

The acquisition advances Lyric’s mission to build the most innovative and impactful company in healthcare decision intelligence. By combining Concert’s proprietary capabilities with Lyric42, Lyric’s Healthcare Decision Intelligence Platform, the company extends its ability to serve clients at a time when advanced diagnostics such as genetic testing and the rapid development of new therapies are reshaping healthcare.

Health plans face urgent demands to manage rising costs and keep pace with rapidly evolving clinical evidence. To meet these demands, plans require solutions that bring policy, data, and decision-making together in the systems they and their providers already use. The combination of Concert’s policy intelligence with the Lyric42 platform delivers that solution to Lyric’s clients at a critical moment.

“Healthcare decision intelligence will define the next decade of this industry, and Lyric is built to lead it,” said Halsey Wise, Lyric CEO. “Healthcare is entering a new era where frontier capabilities are propelling precision diagnostics, personalized therapies, specialty medicines, novel treatment modalities, and rapidly evolving clinical evidence. These themes will all redefine patient care. By combining Concert’s evidence-based, precision medicine capabilities with Lyric’s AI-powered Healthcare Decision Intelligence Platform, we offer our clients critical insights and intelligence. On behalf of our health plan clients, we continue to innovate and activate Lyric42 to create the most unique and powerful decision intelligence platform in the marketplace.”

Concert brings to Lyric a proprietary approach for building machine-readable clinical policy, developed over more than a decade of work in precision health payment accuracy.

“Concert was built on the conviction that clinical and administrative policy should be transparent, evidence-based, and computable, delivered into the systems that health plans and providers actually use to make decisions,” said Rob Metcalf, CEO at Concert…

Full release here, originally announced July 15th, 2026.


SpinSci Acquires Dialog Health, the Leader in Patient Communications for Health Systems

Acquisition Adds Enterprise-Scale RCS-Powered Patient Texting to SpinSci’s Generative AI-Powered Patient Access Solution

SpinSci, the agentic AI company for patient access, today announced it has acquired Dialog Health, a patient communication platform trusted by Fortune 500 health systems, health plans, and ambulatory surgery centers. The acquisition expands SpinSci’s AI-powered patient access platform by adding Dialog Health’s proven patient engagement and communication capabilities, creating a more connected healthcare experience. Together, the companies will deliver a seamless patient journey—from proactive engagement and access to care through workflow automation and issue resolution—while accelerating innovation through greater scale, resources, and investment.

Dialog Health brings a proven two-way texting and RCS platform with reach rates of up to 96%, helping healthcare organizations engage patients through automated workflows and communications that support appointment reminders, confirmations, recall, orders, surveys, billing follow-up, and staff engagement, all through seamless integrations with leading healthcare EHRs and systems. That capability complements SpinSci’s existing Voice AI-powered patient access and notification solutions, giving health systems a unified platform for proactive patient engagement across both voice and text.

“From the start, Dialog Health has been singularly focused on helping healthcare organizations connect with their patients through two-way texting, real conversational engagement, and doing it better than anyone in the space,” said Andy Asava, CEO at SpinSci. “Their platform is trusted by some of the largest health systems in the country, and the results they have delivered speak for themselves. We are honored to welcome this talented team to SpinSci.”

Both companies share a defining trait: a singular, multi-decade focus on healthcare. Dialog Health built its platform specifically for the realities of healthcare communication, including HIPAA, TCPA, and CTIA compliance, rather than retrofitting a generic marketing texting tool. This common focus between SpinSci and Dialog Health makes the integration far deeper than a typical acquisition.

“We have spent more than a decade proving that the right message, at the right time, drives patient action, improves experiences, and protects revenue,” said Sean Roy, CEO at Dialog Health…

Full release here, originally announced July 14th, 2026.



Thursday, July 23, 2026

< + > Why US Hospitals Drown in Claims While Canada Misses Clinical Data

Health information management conferences in Canada rarely focus on claims rejections. This is a stark contrast to the heavy revenue cycle debates dominating US events. While attending the Health Information Day at eHealth26 hosted by CHIMA, Healthcare IT Today sat down with Jodi McMullin, CEO of ScoJo Consulting, to discuss this cross-border divergence in coding practices.

McMullin explained how different funding frameworks completely alter the daily realities for coding professionals. US teams are drowning in billing requirements to secure reimbursement. Canadian teams are desperately searching for missing clinical data to track patient safety.

Core Insight: Distinct funding models drive the sharp divide in how North American hospitals handle claims. However, health information management teams on both sides of the border share a critical mandate: improving clinical documentation accuracy to drive better care decisions and secure stable funding levels.

Funding Models Dictate Code Volume

Claims friction comes down to how healthcare systems are funded. In the US, private funding models require hospitals to bill payers for every specific treatment and historic condition to secure reimbursement. This creates a massive volume of codes per chart, which inherently increases claims denials.

“In the United States, there are so many codes and that’s why they get rejected because the insurance people are auditing them carefully,” McMullin noted. “Whereas in Canada, because it’s a funding portfolio, we don’t.”

Canada’s healthcare funding comes from provincial governments. No sitting political party wants to be seen denying care to voters, making strict claims rejection an instant political disaster.

In the US, payers answer to shareholders seeking to maximize profit. This financial structure drives them to heavily scrutinize every submitted claim.

Catching Up on Clinical Documentation

Despite their different funding mechanisms, both US and Canadian facilities face severe data accuracy challenges. Experienced coders must dig through charts to find missed clinical details, such as adverse reactions or medication challenges.

While the US relies heavily on Clinical Documentation Improvement (CDI) programs to justify billing, Canadian leaders are recognizing these same programs are essential for tracking patient safety and securing proper regional funding.

“If you don’t have the documentation clear from the physicians, then how do you get the accurate data?” McMullin asked. “Without coded data, you don’t get the resources.”

Questions Healthcare IT Leaders are Asking

How do different healthcare funding frameworks change coding workloads between the US and Canada? US healthcare organizations operate in a multi-payer, commercial model that demands line-item justification for every drug, supply, and secondary diagnosis. This forces US coding teams to generate dozens of codes per patient encounter, increasing compliance review times and denial risks. Canadian hospitals operate under regional funding portfolios, meaning teams focus primarily on the main reason for care rather than tracking incidental histories for billing.

Why should Canadian health IT leaders prioritize clinical documentation improvement strategies? Clear documentation is vital for data reliability, resource allocation, and patient safety. When clinicians fail to document specific details, organizations lose the data needed to secure proper regional funding and track hospital harms. Investing in digital workflows and structured clinical documentation programs helps bridge the gap between clinical notes and accurate data tracking.

Learn more about ScoJo Consulting at https://scojocoding.com/

Listen and subscribe to the Healthcare IT Today Interviews Podcast to hear all the latest insights from experts in healthcare IT.

And for an exclusive look at our top stories, subscribe to our newsletter and YouTube.

Tell us what you think. Contact us here or on Twitter at @hcitoday. And if you’re interested in advertising with us, check out our various advertising packages and request our Media Kit.



< + > What Defending a 49-Pharmacy Network Through a War Taught Me About U.S. Small-Practice Healthcare Security

The following is a guest article by Andrii Klepak, Healthcare Technology Founder and DevSecOps Engineer at CloudCare Pro

In May 2026, Chief Healthcare Executive reported what cybersecurity professionals have been seeing for two years. Small hospitals and clinics have emerged as the primary targets of healthcare cyberattacks in the United States. These are not the headline victims in eight-figure ransomware stories. They are the quiet collapses. The solo dermatologist who loses her patient records and never recovers. The five-clinician behavioral health practice that closes after a phishing campaign drains the operating account. The dental office that pays the ransom because the alternative is bankruptcy.

Attackers have followed the money where the defenses are thinnest, and small healthcare providers have been left to defend themselves with budgets that would not fund a full week of incident response at a regional hospital.

Why Small Clinics Became the Target

A 2024 HHS Office for Civil Rights report documented a sharp increase in breaches affecting fewer than 500 individuals, the category that captures most small-practice incidents. The economic logic on the attacker side is straightforward. A 200-bed hospital has a SOC, a CISO, threat-intelligence feeds, a hardened backup architecture, and a legal team. A solo dermatology practice has a front-desk manager who also handles password resets. Both are subject to identical HIPAA Security Rule obligations under §164.306. Only one is positioned to actually meet them.

Three structural reasons drive this trend. Software fragmentation –  a typical small practice runs five or six unintegrated vendor products, each a separate attack surface. “HIPAA-compliant” claims at the vendor layer that do not survive scrutiny. And the absence of any internal cybersecurity capacity at the practice itself. Small practices with fewer than ten staff typically have annual security budgets below twenty thousand dollars, total. That is not a posture. That is a wish.

What We Did at a 49-Pharmacy Network During Wartime

For six years, I was the lead infrastructure engineer for a 49-location pharmacy network operating across four regions of Western Ukraine. In December 2021, the network began migrating its entire IT operation from on-premises servers to public cloud infrastructure. Within ten weeks of the project’s start, Russia invaded Ukraine. The most intense phase of that migration production cutover, electronic-prescription integration, identity federation, verified-restore backup testing – happened through February and March 2022, in the hot phase of the invasion. The migration completed that spring.

The pharmacies stayed open. The electronic-prescription system kept working. One million citizens who depended on that network for essential medication were able to fill scripts in the safer west because the data had been moved out of buildings that were now sometimes being shelled. American small clinics are not being bombed. The structural problem is similar in a way that has been difficult to unsee. Critical healthcare services depend on infrastructure that the people running it cannot afford to defend.

Five Disciplines a Small Practice Actually Needs

First, federated identity. The practice runs on one identity provider with single sign-on, and every staff login has two-factor authentication. Revoking access for a former employee takes one click, not a tour of every separate vendor portal. HIPAA §164.312(a) requires access control. In practice, that means an SSO provider, not Post-it notes on the front-desk monitor.

Second, encryption that can be verified, not just encryption that is claimed. Data at rest needs to be encrypted with keys that the practice or its Business Associate vendor actually controls. Data in transit needs TLS 1.2 or higher. The verifiable test is to ask the vendor in writing where the encryption keys live and who has access.

Third, a real audit log. The regulation expects evidence of which user accessed which patient record and when. Many vendor logs record only authentication events. Ask the vendor for the audit trail of every read of a single patient record over the past 90 days. If the answer is logins but not record-level access, that vendor is not aligned with §164.312(b). The next generation of audit logs is cryptographically hash-chained – altering a historical entry visibly breaks the chain.

Fourth, a Business Associate Agreement that covers the actual workflow. If an AI scribe sends patient data to a third-party model provider, there must be a BAA covering that flow. There almost never is at the small-practice tier. The defensible workaround is strict PHI redaction at the practice boundary, so the model provider never sees protected information and therefore is not a Business Associate at all.

Fifth, a backup strategy that has been tested. Ransomware against small healthcare is profitable precisely because the backups, when they exist, have not been verified. The minimum is daily backups, stored separately, encrypted, and restored in a tabletop test at least once per year. The tabletop is non-negotiable.

Five Questions Every Small-Practice Owner Should Send to Every Vendor

Most security failure in small healthcare originates at the vendor layer rather than the practice layer. The practical leverage point is the vendor relationship. Five matters every small-practice owner should confirm in writing before signing or renewing any software contract: whether a current signed Business Associate Agreement exists and whether a copy can be sent; where the encryption keys for patient data are stored and who can access them; whether the audit log can produce every read of a single patient record over the past 90 days; whether any AI feature is covered by a BAA or PHI is redacted before transmission, or both; and what the contractual breach-notification obligation and timeline are. A vendor that cannot answer in writing is not HIPAA-aligned.

The fix for U.S. small-practice security is not enterprise security at enterprise prices. It is the discipline of multi-account isolation, of verified encryption, of real audit logs, of honest BAA coverage, and of restored backups. These disciplines existed before the war, which taught me what catastrophic infrastructure failure looks like. They are now the table stakes for any healthcare practice that intends to be operating in five years. (I have previously written about the foundational DevSecOps practices small clinics can adopt.)

About Andrii Klepak

Andrii Klepak is a Healthcare Technology Founder and DevSecOps Engineer based in Hoffman Estates, Illinois. He is the Founder of CloudCare Pro, a healthcare-software company building HIPAA-aligned tools for small U.S. clinics. He led the cloud-infrastructure migration described in this article from December 2021 through spring 2022. He is an AWS Certified Solutions Architect, a Certified Kubernetes Administrator, and a member of HIMSS and ACM. Connect with him on LinkedIn.



< + > Inner Logic Raises $11.5 Million Seed Round | MitoSense and Aquila Health Enter Strategic Partnership

Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.


Inner Logic Raises $11.5 Million Seed Round to Build Autonomy-Enabling Infrastructure for Procedural Devices

Inner Logic (formerly Semaphor) today announced an $11.5 million seed round co-led by General Catalyst and Bison Ventures with participation from J2VP, Defined, PTX, Valia Ventures, Page One, Alumni Ventures, and Flare. Inner Logic gives device manufacturers the infrastructure to design, test, and validate procedural devices across thousands of virtual patients and procedures before clinical deployment. The same infrastructure provides the capabilities needed to make surgical autonomy a reality.

“Surgery is on the same path as autonomous driving, which became real once the industry built the simulation and data systems to show a car could drive itself. At Inner Logic, we are building that layer for all of procedural medicine, starting with the way devices are designed and tested. When device makers can develop and prove intelligent systems this way, the quality of a patient’s care stops depending on which hospital they can access or which surgeon is on call,” said Tito Porras, MD, Co-Founder and CEO at Inner Logic.

Inner Logic was co-founded by CEO Tito Porras, MD, who left his neurosurgery residency at Johns Hopkins Hospital to build the company; CTO Mathias Unberath, PhD, an award-winning computer vision and simulation researcher at Johns Hopkins Whiting School of Engineering; and Chief Robotics Officer Axel Krieger, PhD, an associate professor at Johns Hopkins Whiting School of Engineering, whose robot performed the first autonomous laparoscopic surgery in a live animal. Together, the founders have authored more than 400 peer-reviewed publications and are named inventors on over 40 patents.

Today, much of the exploratory work in device development still happens in the physical world. Teams build prototypes, test them in cadaver labs or animal studies, and learn what works, one experiment at a time. Each iteration is expensive and covers only a narrow slice of the patients a device will encounter. What one program learns rarely carries into the next.

Inner Logic moves that work into simulation, where device teams can design and test across thousands of virtual patients overnight. Those virtual patients are built from real clinical and procedural data, so what teams learn in simulation holds up in the physical world…

Full release here, originally announced July 22nd, 2026.


MitoSense and Aquila Health Enter Strategic Partnership to Build AI-Ready Data Infrastructure for Mitochondrial Medicine

Built on Aquila’s TREUE Standard, the Collaboration will Create a Governed, Longitudinal Data Foundation for Mitochondrial Medicine

MitoSense, Inc., a biotechnology company developing therapies that restore function for neurodegenerative, metabolic, and other diseases linked to mitochondrial dysfunction, today announced a strategic partnership with Aquila Health PBC, a healthcare data infrastructure company, to create an artificial intelligence-ready data foundation for its research, future clinical programs, and commercial activities. The collaboration is expected to help researchers better understand disease progression and treatment response in conditions such as ALS, Parkinson’s disease, Alzheimer’s disease, Long COVID, and HIV.

As MitoSense’s strategic partner, Aquila will use its TREUE standard to create a governed, complete patient view by connecting fragmented healthcare data across systems. This addresses a central challenge in advanced medicine: researchers cannot fully understand disease progression, treatment response, and long-term outcomes without understanding the whole patient. Despite healthcare generating enormous volumes of data, an estimated 97% goes unused, leaving researchers with incomplete patient records that make it difficult to gain a multi-dimensional understanding of patient health over time. 

For an emerging field such as mitochondrial medicine, this is particularly critical, as patient response may be shaped by medications, therapies, coexisting conditions, organ function, inflammation, metabolism, immune response, and long-term disease progression. For example, if a patient with ALS experiences slower disease progression, or a patient with Alzheimer’s disease demonstrates changes in cognitive function during a future clinical study, researchers need to understand whether those outcomes are associated with the investigational therapy or influenced by other medications, underlying conditions, or unrelated clinical factors. Without that context, important signals can be missed or clinical outcomes misinterpreted.

“Mitochondrial medicine will require a new kind of data backbone,” said Van Hipp, Chairman at MitoSense. “We are working in an area where patient history, medications, biomarkers, safety signals, clinical outcomes, and long-term follow-up all matter. To understand whether a patient is improving, stable, or experiencing a setback, we need to understand the whole patient, including what other drugs or therapies may be affecting their health. Aquila brings the governed, AI-ready infrastructure needed to connect those pieces responsibly. This partnership is about making sure the data foundation is ready for the science.”

Rather than requiring healthcare organizations to move sensitive patient information into a centralized repository, Aquila securely connects data where it already resides, allowing researchers to generate insights while organizations maintain control of their data. The companies will continue to evaluate how Aquila’s TREUE standard and related AI capabilities support MitoSense’s clinical research, outcome analytics, data management initiatives, and future project-based engagements. In time, the AI data foundation is expected to help MitoSense identify meaningful biomarkers, monitor safety, and generate the evidence needed to advance development of treatment programs.

Aquila is led by Dr. Jaime Bland, DNP, RN, Co-Founder and Chief Executive Officer. Dr. Bland previously served as President and CEO of CyncHealth, where she helped build and operate a multi-state health information exchange network supporting data coordination across more than six million lives.

“Healthcare does not suffer from a lack of data. It suffers from fragmented data that cannot be used together responsibly,” said Dr. Jaime Bland, Co-Founder and CEO at Aquila Health PBC. “MitoSense is advancing science that will require longitudinal, multi-source evidence across clinical, laboratory, biomarker, medication, and outcome data. Aquila was built to make that kind of data usable, secure, governed, and ready for advanced analytics without forcing organizations into a single centralized warehouse. We are excited to work with MitoSense to explore how our infrastructure can support clinical research, translational science, and future evidence generation.”

MitoSense is currently advancing preclinical and regulatory groundwork towards Phase 1 clinical trials, with Aquila’s AI data infrastructure planned to support future studies through the mitochondrial medicine platform.

About MitoSense

MitoSense, Inc. is a biotechnology company focused on mitochondrial health and mitochondrial organelle transplantation technologies. The company is developing platforms intended to study and address mitochondrial dysfunction across high-impact translational applications, including neurodegenerative disease, post-viral syndromes, and other conditions where impaired cellular energy may play an important role. MitoSense is also building a growing network of scientific, clinical, patient-advocacy, and translational relationships, including collaborations and engagements with James A. Haley Veterans; Hospital, Walter Reed Army Institute of Research (WRAIR) through Cooperative Research and Development, Agreements (CRADAs), Greenwood Genetic Center, and Hop On a Cure. These relationships support MitoSense’s strategy of advancing mitochondrial science through disciplined research partnerships, patient- centered insight, and real-world evidence generation, focused on specific clinical, longevity, or anti-aging outcomes in the future. For more information, please visit mitosense.com.

About Aquila Health PBC

Aquila Health PBC is a Delaware public benefit corporation focused on healthcare data infrastructure, artificial intelligence, information exchange governance, and population health analytics. Its TREUE platform is designed to normalize and mobilize fragmented health data across organizations, systems, and geographies, enabling longitudinal, multi-source data integration for research, clinical decision-making, public health, and regulated healthcare environments. For more information, please visit aquilahealth.com.

Originally announced July 21st, 2026.



Wednesday, July 22, 2026

< + > Moving HIM from the Back Office to Strategic Leadership: Insights from CHIMA

Modern healthcare data demands far more than basic classification. With clinical data volumes exploding and automated tools entering the workflow, the role must expand into data integrity. Survival depends on turning static medical records into highly accurate, operational assets.

Healthcare IT Today sat down with Mahmoud Suleiman, CEO and Registrar at the Canadian Health Information Management Association (CHIMA). We discussed the accelerating evolution of the profession. Health systems must stop treating these teams as transactional encoders and start treating them as strategic data stewards.

Key Takeaways about the HIM Evolution

  1. Shift your teams out of the coding silo and into data governance. Modern information professionals are moving beyond the billing department to step into critical leadership roles like data privacy and data security.
  2. Redefine the profession around broad data versatility. The historical focus on basic paper and electronic medical records is giving way to a much wider operational footprint.
  3. Prioritize strict data stewardship to protect clinical outcomes. Automated systems and analytical models depend entirely on the integrity of the data points fed into them.

Moving Beyond the Billing Department

Hospital executives often look at HIM as just coders for billing and reimbursement. This narrow focus limits your organization’s operational capability. Forward-thinking leaders are actively deploying their HIM experts in high-level oversight roles to protect data architecture.

“There are a good number [of our members] that are coders, but we’re finding there are people part of clinical documentation improvement, release of information,” Suleiman explained. “We’re looking at individuals who are at the governance levels – as chief privacy officers, chief information officers.”

Embracing Full Data Versatility

Modern health information management goes beyond accurate patient charts. It requires extracting data from every back-end system. This demands a dynamic understanding of information flow across systems. HIM professionals are uniquely positioned to manage this.

Suleiman pointed this out during our conversation: “In the past [our work has been] around medical records, but now it’s evolved into being a wide and versatile type of profession.”

Protecting Data Quality for Better Outcomes

Bad data produces bad outcomes, especially as health systems begin to feed information into analytical algorithms. Guarding against this requires strict data stewardship. Teams must focus on accuracy at the point of ingestion. If your data foundation is weak, your clinical decision tools will fail.

Suleiman emphasized that quality remains the core priority for modern HIM teams. “How are they ensuring that there’s, that quality piece is still integrated into the work?” he asked. “Because again, if we have poor quality data, we will have poor quality outcomes.”

The Bottom Line

Leaving your information management team buried in traditional coding workflows is an operational mistake. The success of modern health IT infrastructure depends entirely on the accuracy and security of your data.

By repositioning these professionals as active data stewards, health systems gain the oversight needed to manage complex information pipelines safely. It’s something that CHIMA is actively working on.

Questions Healthcare IT Leaders Are Asking

How is the role of health information management professionals changing? The profession is transitioning away from manual entry, coding, and reimbursement tasks toward high-level data governance and stewardship. Organizations are increasingly placing these professionals into strategic roles where they oversee data integrity, privacy compliance, and clinical documentation improvement across the entire organization.

Why should health IT leaders focus on data stewardship over simple coding? Simple coding only addresses the retrospective classification of care for billing purposes, whereas data stewardship ensures real-time accuracy and security. Without strict stewardship, poor data quality corrupts clinical algorithms and operational reporting.

What operational impact does data quality have on healthcare technology deployments? Data quality acts as the foundation for every digital tool. Introducing flawed data into advanced clinical systems or administrative software leads directly to operational errors and poor patient care. Ensuring high data quality through trained information specialists protects technology investments and stabilizes workflows.

Learn more about CHIMA at https://www.echima.ca/

Listen and subscribe to the Healthcare IT Today Interviews Podcast to hear all the latest insights from experts in healthcare IT.

And for an exclusive look at our top stories, subscribe to our newsletter and YouTube.

Tell us what you think. Contact us here or on Twitter at @hcitoday. And if you’re interested in advertising with us, check out our various advertising packages and request our Media Kit.



< + > This Week’s Health IT Jobs – July 22, 2026

It can be very overwhelming scrolling through job board after job board in search of a position that fits your wants and needs. Let us take that stress away by finding a mix of great health IT jobs for you! We hope you enjoy this look at some of the health IT jobs we saw healthcare organizations trying to fill this week.

Here’s a quick look at some of the health IT jobs we found:

If none of these jobs fit your needs, be sure to check out our previous health IT job listings.

Do you have an open health IT position that you are looking to fill? Contact us here with a link to the open position and we’ll be happy to feature it in next week’s article at no charge!

*Note: These jobs are listed by Healthcare IT Today as a free service to the community. Healthcare IT Today does not endorse or vouch for the company or the job posting. We encourage anyone applying to these jobs to do their own due diligence.



< + > Breaking Clinical Data Chaos – Life Sciences Today Podcast Episode 71

We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Raj Indupuri, Co-...